Powershares DB G10 Currency Harvest Fund 

(Public, NYSE:DBV)   Watch this stock   
Find more results for DBV

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 17355.47% -1727.22%
Operating margin -407.30% 53.52%
EBITD margin - -
Return on average assets 26.60% -36.68%
Return on average equity 26.77% -36.70%

Address

C/o DB Commodity Services LLC 60 Wall Street
New York, 10005
United States - Map
+1-212-2505883 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance

Powershares DB G10 Currency Harvest Fund discussions

  View all discussions »

Description

Powershares DB G10 Currency Harvest Fund (the Fund) and its subsidiary, DB G10 Currency Harvest Master Fund (the Master Fund), seek to track changes, whether positive and negative, in the level of the Deutsche Bank G10 Currency Future Harvest Index-Excess Return (the Index), over time, plus the excess, if any, of the Master Fund’s income from its holdings of United States Treasury obligations and other short-term fixed income securities. The Index is designed to reflect the return from investing on a 2:1 leveraged basis in long currency futures positions for certain currencies associated with relatively high yielding interest rates and in short currency futures positions for certain currencies associated with relatively low yielding interest rates. DB Commodity Services LLC serves as the managing owner, commodity pool operator and commodity trading advisor of each of the Fund and the Master Fund.

Officers and directors

Hans Ephraimson
Chief Executive Officer, Member of the Board of Managers
Age: 44
Bio & Compensation - Reuters
Michael Gilligan
Principal Financial Officer of the Manager
Age: 42
Bio & Compensation - Reuters
Martin Kremenstein
Chief Operating Officer, Vice President, Chief Investment Officer, Member of the Board of Managers
Age: 32
Bio & Compensation - Reuters
Alex Depetris
Member of the Board of Managers
Age: 29
Bio & Compensation - Reuters